3D Medicines
Minhang
About 3D Medicines
3D Medicines, we use individual’s genetic information to prevent, diagnose, and treat cancer. We develop personalized medicines according to target population’s genetic background, to increase efficacy and safety.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 501 – 1,000
- Estimated revenue: $500K – $1M
- Total funding: $505.9M
- Funding stage: IPO
- Last round: Series D (Nov 2020)
- Ticker: hkg:1244
- Website: 3dmedcare.com
- Phone: (86)021-34796586
Industries & Categories
Biopharma, Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/3d-medicines-83970 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.